Bristol-Myers Squibb buy BiotechBee
Start price
07.09.22
/
70%
€69.37
Target price
31.12.25
€100.00
Performance (%)
-12.07%
End price
05.05.23
€61.00
Summary
This prediction ended on 05.05.23 with a price of €61.00. The prediction for Bristol-Myers Squibb disappointed with a performance of -12.07%. Dividends of €1.61 are taken into consideration when calculating the performance. BiotechBee has 70% into this predictionPerformance without dividends (%)
Name | 1w | 1m | 1y |
---|---|---|---|
Bristol-Myers Squibb | 4.746% | 4.746% | -22.301% |
iShares Core DAX® | 2.147% | 2.681% | 17.410% |
iShares Nasdaq 100 | -0.578% | -0.816% | 24.107% |
iShares Nikkei 225® | 0.635% | 3.079% | 16.921% |
iShares S&P 500 | 0.746% | 0.171% | 23.802% |
According to BiotechBee what are the pros and cons of Bristol-Myers Squibb for the foreseeable future?
Pros
Could be very worthwhile Investment >20% year
Cons
Comments by BiotechBee for this prediction
In the thread Bristol-Myers Squibb diskutieren
Buy mit Kursziel 100,0
In the thread Trading Bristol-Myers Squibb
Buy beendet